Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
                        
                            
                                申请人:AVENTIS PHARMA DEUTSCHLAND GMBH
                            
                            
                                公开号:US20040167120A1
                            
                            
                                公开(公告)日:2004-08-26
                            
                            Pyrimidine-4,6-dicarboxylic acid diamides of the formula I
1
are suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerative joint diseases.
                            式I1的
嘧啶-4,6-二
羧酸二酰胺适用于选择性抑制
胶原酶(MMP13)。因此,
嘧啶-4,6-二
羧酸二酰胺可用于治疗退行性关节疾病。